Loading term…
Assessment of whether a given RWD source is adequate for the intended PV or safety question (completeness, accuracy, relevance, timeliness).
Evaluating if a claims database has sufficient drug exposure and outcome capture for a specific AE.
EMA RWD/RWE reflection paper, FDA RWE guidance
Using convenience datasets without documented fitness-for-use assessment.
How do you document fitness for use of RWD in your analyses?